Vasu Vats

Vasu Vats has extensive experience in the pharmaceutical industry, currently serving as Vice President and Global Head of Marketing for Inflammation and Immunology at Pfizer since September 2006. Vasu has held several key positions at Pfizer, including Global Commercial Lead for Xeljanz and Etrasimod, as well as leadership roles in areas such as Eliquis, internal medicine strategy, and cardiovascular and metabolic diseases. Vasu's expertise also extends to marketing management and strategy enablement, with previous positions in market access and outcomes research. In addition, Vasu is a member of the Board of Advisors for MaMome and a Young Global Leader at the World Economic Forum. Vasu holds a Master of Public Health in International Community Health from New York University.